Flexen glow skin gel treat muscle pain, sprain, bruising, dislocated (50g)

Dosage form Tube x 50g
Specifications Ketoprofen

Ingredient

Composition information	Content
Ketoprofen	2.5%

Uses

Indications

In place in the following cases: muscle pain, sprains, bruises, dislocated joints, baritis, tendonitis, tendonitis, intravenitis, surface venous inflammation and lymphitis.

Pharmacokology

Pharmacological classification: Non -steroid anti -inflammatory drugs (NSAID) for local use.

ATC code: mo2aato.

Ketoprofen, in a suitable dozer, can be absorbed through the skin in inflammatory organizations thereby allowing local treatment to reduce pain, anti -arthritis, tendon, ligaments and muscles. In coordination with appropriate systemic treatments. The drug also contributes to reducing the surface inflammation of the skin, lymph vessels and lymph nodes.

Dynamic pharmacy

very little skin absorption drugs. When applying 250mg of ketoprofen skin, the active ingredient in plasma is about 0.20 - 0.36mcg/ml after 4 - 10 hours of use.

Before taking Flexen glow skin gel treat muscle pain, sprain, bruising, dislocated (50g)

How to use

Apply skin.

Dosage

Apply 1-2 times daily, gel area is about 3 - 5cm, depending on the area of the damage area, gently massage to increase the absorption of the drug.

What to do when overdose? If you accidentally eat medicine, you can cause systemic side effects depending on the amount of food.

However, in this case, the symptoms and supportive measures are the same as in the case of anti -inflammatory overdose.

In case of accidental or overdose of 2.5% gel flexen, immediately notify the doctor or go to the nearest hospital.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Do not use double the prescribed dose.

Side Effects

Like all other drugs, Flexen Gel can cause unwanted effects, although it is not an expression on all drug users.

Like all skin -use drugs, there can be unwanted effects on the skin.

The ratio and degree of this unwanted effect are significantly reduced by preventing exposure to sunlight, including sunbathing, during treatment and 2 weeks after stopping the drug.

The level of these effects is classified as follows: Very common (≥ 1/10), common (≥ 1/100,

immune system disorders

Unknown

: Anaphylaxis, angels, hypersensitivity reactions.

Pathology of skin and subcutaneous tissue

Unknown

: local skin reactions like erythema, burning sensation.

Rare: skin reaction: sensitive to light, hives. More rare cases of more serious reactions such as blistering or water -glossy eczema, they can spread out of the treatment or body.

Kidney - Urology

Very rare: the worsening case of the previous kidney failure.

Warnings

Contraindicated

Flexen is contraindicated in the following cases:

Hypersensitivity to the main active ingredient or any excipients of the drug. Tenofibral, UV sunscreen or scents.

Avoid exposure to the skin being treated with sunlight or UV rays of the sun during the treatment process and 2 weeks after the drug stopped.

Precautions when using

Be careful when using flexen for patients with heart, liver and kidney function impairment: The body's adverse reaction is related to kidney function.

No wound covering.

Do not let the gel come into contact with the mucosa or eye. Avoid using Flexen 2.5% on open wounds or continuous damaged skin.

Stop use immediately if there are reactions on the skin even in case of reaction after use simultaneously with products containing octocrylen.

To avoid the risk of light sensitivity, recommend the protection of the skin treatment area during the treatment process and two weeks after stopping the drug.

Wash your hands carefully after each medication.

The recommended treatment should not be prolonged because of the risk of contact dermatitis and sensitivity to sunlight increases over time for treatment.

Patients with asthma have to be related to chronic rhinitis, chronic sinusitis and nasal polyps that are at higherness to increased allergic reactions with aspirin and or nsAIDs.

Safety and effectiveness of ketoprofen gel in children has not been evaluated.

This product contains para-hydroxy-benzoate so it can cause allergic reactions, usually slow allergies.

The use, especially if prolonged, medications used in place can cause sensitive or local irritating phenomena. In this case, it is necessary to stop treatment and consult a doctor.

The ability to drive and operate machinery

There is no effect of the drug until the driver's ability to drive and operate machines is known.

Pregnancy and lactation

Pregnancy

The first three months and the middle three months of pregnancy: Due to the safety of ketoprofen during pregnancy has not been evaluated. Therefore, ketoprofen should not be used in the first 3 months and 3 months of pregnancy.

The last three months of pregnancy: In the last three months of pregnancy, all Prostaglandin synthesis inhibitors, including ketoprofen, can cause fetal and kidney poisoning in the fetus.

At the end of pregnancy, prolonged bleeding time in both mother and child may occur: Therefore, Ketoprofen is contraindicated in the last 3 months of pregnancy.

Breastfeeding period: There is no data on the excretion of ketoprofen in breast milk.

Ketoprofen is not recommended for breastfeeding mothers.

Medicinal interaction

Interaction with other drugs is hard to occur because the Ketoprofen concentration in serum after skin is very low.

There is no interaction of Flexen Gel 2.5% with other drugs found.

However, monitoring patients who are using cooumarin is necessary.

Storage

Store at temperatures below 30 ° C, avoid sunlight.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.